Results 151 to 160 of about 121,181 (280)

Indobufen Dual Antiplatelet Therapy (DAPT) Versus Aspirin Dual Antiplatelet Therapy (DAPT) After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta‐Analysis

Catheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 1225-1236, March 1, 2026.
ABSTRACT Background Dual antiplatelet therapy (DAPT), which combines aspirin with a P2Y12 receptor inhibitor, is considered the standard of care for patients who have had percutaneous coronary intervention (PCI). This study aimed to compare indobufen‐based (DAPT) to aspirin‐based (DAPT) after PCI.
Omar Saeed, Abdelrahman Saeed, Osama Barakat, Abdulaziz Bawjeh, Tuğba Saka, Tasneem Mustafa Yousif, Aeshah Mohammed Adim, Muhammed Elhadi, Mamas A. Mamas   +8 more
wiley   +1 more source

AI Interpretation of Ruijuhokogi Headnotes: A Descriptive Preliminary Evaluation Using Microsoft Copilot

Traditional &Kampo Medicine, Volume 13, Issue 1, April 2026.
Yoshinobu Nakada, Masayoshi Koinuma, Daigo Taniguchi, Makoto Arai, Tatsuya Nogami   +4 more
wiley   +1 more source

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial

Clinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 782-790, March 2026.
Verekitug, a novel, high‐affinity, fully human monoclonal antibody targeting thymic stromal lymphopoietin receptor (TSLPR), is in development as a potential treatment for severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD).
Dave Singh, Chaim M. Brickman, Peter Lloyd, Ashish Kalra, Subhabrata Biswas, Arkadeep Sinha, Alex Mulvanny, Sumathi Sivapalasingam, Oren M. Becker, Aaron Deykin   +9 more
wiley   +1 more source

Urinary and Plasma Profiles of Betamethasone and Triamcinolone Acetonide Following Intra‐Articular and Related Administrations

Drug Testing and Analysis, Volume 18, Issue 3, Page 426-438, March 2026.
Intra‐articular and periarticular administrations of betamethasone and triamcinolone acetonide produce systemic effects, with compound‐ and route‐dependent profiles. The results support the MRLs in urine established by WADA and recommend increasing the washout period for betamethasone.
Sergi Coll, Claudia Bressan, Núria Monfort, Jone Llorente‐Onaindia, Jordi Monfort, Jordi Santiago, Ramon Balius, Daniel Brotons, Rosa Ventura   +8 more
wiley   +1 more source

Dyspepsia following <i>Helicobacter pylori</i> eradication: Shifts in etiology and clinical challenges. [PDF]

World J Gastroenterol
Lu JG, Gao YZ.
europepmc   +1 more source

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta‐Analysis of Randomised Controlled Trials

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 2, March 2026.
This network meta‐analysis compares emerging glucagon receptor agonists for obesity and type 2 diabetes. Retatrutide and survodutide demonstrated the most favourable efficacy profiles for weight reduction with acceptable safety, supporting their potential as promising therapeutic options and highlighting the need for future head‐to‐head clinical trials.
Ayah Abulehia, Hazem Ayesh, Omar Ayesh, Doha Jaber, Thekrayat Asad, Adham Itbaisha, Hamzeh Abugharbieh, Raged Gharbia, Lila H. Abu‐Hilal, Barbara Gisella Carranza Leon   +9 more
wiley   +1 more source

Appropriate prescribing and deprescribing of proton pump inhibitors: New Choosing Wisely Canada toolkit. [PDF]

Can Fam Physician
Bland E, van Zanten SV, Thompson W.
europepmc   +1 more source

Dyspepsia

International Journal of Clinical Practice, 1953
openaire   +2 more sources

A Randomised Controlled Trial Testing the Efficacy of an Educational Website About Functional Abdominal Pain for Children and Adolescents

European Journal of Pain, Volume 30, Issue 3, March 2026.
ABSTRACT Background Functional abdominal pain (FAP) is a severely debilitating condition affecting approximately 11.7% of children and adolescents worldwide, often persisting into adulthood and significantly restricting daily life. Health literacy is essential for treatment success. To improve knowledge about the biopsychosocial factors influencing FAP
Verena Neß, Clarissa Humberg, Lisa‐Marie Rau, Leandra Eidt, Thomas Berger, Martin Claßen, Nils Christian Syring, Jens Berrang, Christine Vietor, Stephan Buderus, Gerrit Hirschfeld, Christina Becker‐Emden, Julia Wager   +12 more
wiley   +1 more source

Efficacy and Safety of Lisdexamfetamine Versus Topiramate Versus Naltrexone/Bupropion in Individuals With Binge Eating Disorder: A Network Meta‐Analysis

European Eating Disorders Review, Volume 34, Issue 2, Page 334-346, March 2026.
ABSTRACT Objective To compare the efficacy and safety of lisdexamfetamine, topiramate, and naltrexone/bupropion for treating binge eating disorder (BED) using network meta‐analysis. Method We systematically searched PubMed, Scopus, ClinicalTrials.gov, and Cochrane Central up to February 2025 for randomized controlled trials evaluating these medications
Tamer Hodrob, Ibrahim Ismail, Alaaeddin Abusalameh, Celina R. Andonie, Omar Ayesh, Hazem Ayesh   +5 more
wiley   +1 more source